Santilli J, Nathan R, Glassheim J, Rockwell W
Ann Allergy Asthma Immunol. 2001 Feb;86(2):219-21. doi: 10.1016/S1081-1206(10)62694-4.
Outcomes measurement is a proficient method in determining the effectiveness of medical therapy. Currently, there are no easy-to-use and inexpensive questionnaires available to evaluate the effectiveness of immunotherapy by allergists in private practice.
To evaluate the effectiveness of immunotherapy in the treatment of patients with allergic rhinitis in a private practice setting using the rhinitis outcomes questionnaire (ROQ).
One hundred seventy-five patients were randomly chosen from three private practices nationwide. They were surveyed regarding global systemic problems and nasal, eye, and chest symptoms, as well as their medical treatment history. This questionnaire was administered twice in one sitting, with the first a recall of symptoms before immunotherapy treatment, and the second an evaluation of current symptoms.
The data revealed that 81% of the patients believed immunotherapy worked, with 19% unsure. Patients experienced a 67% decrease in antibiotic use, a 68% decrease in emergency room visits, a 75% decrease in days lost from work or school, and a 79% decrease in hospital admissions. The average symptom score reduction with immunotherapy was 52%.
This study demonstrates that the user-friendly ROQ can be effectively and inexpensively used in a private practice setting and that immunotherapy is effective in the treatment of allergic rhinitis.
疗效评估是确定医学治疗效果的一种有效方法。目前，在私人诊所中，过敏症专科医生没有简便且廉价的问卷来评估免疫疗法的效果。
使用鼻炎疗效问卷（ROQ）评估在私人诊所环境中免疫疗法治疗过敏性鼻炎患者的效果。
从全国三家私人诊所中随机选取175名患者。对他们进行了关于全身系统性问题、鼻、眼和胸部症状以及其治疗史的调查。该问卷在一次就诊过程中进行了两次填写，第一次是回忆免疫疗法治疗前的症状，第二次是评估当前症状。
数据显示，81%的患者认为免疫疗法有效，19%不确定。患者使用抗生素的次数减少了67%，急诊就诊次数减少了68%，误工或误学天数减少了75%，住院次数减少了79%。免疫疗法使症状平均评分降低了52%。
本研究表明，用户友好的ROQ可在私人诊所环境中有效且廉价地使用，并且免疫疗法在治疗过敏性鼻炎方面是有效的。
